XOMA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
XOMA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).
Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.
XOMA Royalty's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.
For the Biotechnology subindustry, XOMA Royalty's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, XOMA Royalty's Margin of Safety % (DCF FCF Based) distribution charts can be found below:
* The bar in red indicates where XOMA Royalty's Margin of Safety % (DCF FCF Based) falls into.
Thank you for viewing the detailed overview of XOMA Royalty's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.
Biotechnology Value Fund L P | other: See Explanation of Responses | 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104 |
Bradley Sitko | officer: Chief Investment Officer | C/O XOMA CORPORATION, 2200 POWELL STREET, SUITE 310, EMERYVILLE CA 94608 |
Thomas M. Burns | officer: Chief Financial Officer | 2910 SEVENTH STREET, BERKELEY CA 94710 |
Owen Hughes | director, officer: Interim CEO | C/O RADIUS HEALTH, INC., 201 BROADWAY, 6TH FLOOR, BOSTON MA 02139 |
James R Neal | officer: VP Business Development | 2910 SEVENTH STREET, BERKELEY CA 94710 |
Heather L Franklin | director | C/O ZYMOGENETICS, INC., 1201 EASTLAKE AVE E, SEATTLE WA 98102 |
Natasha Hernday | director | 932 SOUTHWOOD BLVD, INCLINE VILLAGE NV 89451 |
Bvf Ii Gp Llc | 10 percent owner | 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104 |
Bvf Gp Holdings Llc | 10 percent owner | 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104 |
Bvf I Gp Llc | 10 percent owner | 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104 |
Van Ness W Denman | director | C/O XOMA LTD, 2910 SEVENTH ST., BERKELEY CA 94710 |
Barbara Kosacz | director | 3175 HANOVER STREET, PALO ALTO CA 94304 |
Deepshikha Datta | officer: Chief Business Officer | 2200 POWELL STREET, SUITE 310, EMERYVILLE CA 94608 |
John Varian | director, officer: Director and CEO | ARYX THERAPEUTICS,INC., 6300 DUMBARTON CIRCLE, FREMONT CA 94555 |
Matthew D Perry | director, other: See Explanation of Responses | ONE SANSOME STREET, 30TH FLOOR, SAN FRANCISCO CA 94104 |
From GuruFocus
By GuruFocus News • 12-20-2024
By Marketwired • 10-22-2024
By Marketwired • 08-13-2024
By Marketwired • 09-04-2024
By GuruFocus Research • 05-10-2024
By Marketwired • 09-23-2024
By GuruFocus Research • 09-27-2024
By Marketwired • 06-20-2024
By Marketwired • 02-04-2025
By GuruFocus Research • 02-09-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.